CFTR and cystic fibrosis: The potentiator Ivacaftor enhances the ATP-independent opening of the CFTR channel and thereby overcomes the defective ATP-dependent opening of CF-causing gating mutations (Van Goor et al., 2009; Eckford et al., 2012).